M

MedinCell

150 employees

MedinCell is an injectable slow-release drug specialist company.

Basic info

Industry

pharmaceutical manufacturing

Sectors

global health
pharmaceutical industry
patient safety
chronic pain
Health innovation
mental health
Pharmaceutical
drug delivery
patient care
generic
Polymer chemistry
R&D
controlled release
medical devices
compliance
pain control
long acting drug
API
joint ventures

Date founded

2002

Funding rounds raised

Total raised

$42M

from 7 investors over 7 rounds

M

MedinCell raised $42M on November 24, 2022

Investors: European Investment Bank

M

MedinCell raised $36M on February 11, 2021

Investors: BNP Paribas Développement, Seventure Partners, Mirova Natural Capital and Crédit Mutuel Innovation

M

MedinCell raised $19M on November 29, 2019

Investors: Bill & Melinda Gates Foundation

M

MedinCell raised $24M on March 1, 2018

Investors: European Investment Bank

FAQ